Showing results (301-310 of 369) with videos related to

Sort By:
Pageof 37
Blood Advances|November 15, 2023
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experienceRohan Shotton, Rachel Broadbent, Alia Alchawaf, et al.
Cancers|March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
The Oncologist|January 16, 2021
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of TherapySuzanne George, Robin L Jones, Sebastian Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2019
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)Roberta Sanfilippo, Robin L Jones, Jean-Yves Blay, et al.
The Oncologist|July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS StudyJohn R Zalcberg, Michael C Heinrich, Suzanne George, et al.
Future Oncology (London, England)|April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcomaMrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlatesJanelle M Meyer, Kelly S Perlewitz, James B Hayden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2022
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III TrialSebastian Bauer, Robin L Jones, Jean-Yves Blay, et al.
The Lancet. Oncology|June 26, 2007
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective studyFederica Grosso, Robin L Jones, George D Demetri, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2021
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European studyMahmoud Mohammadi, Nikki S IJzerman, Peter Hohenberger, et al.
Pageof 37